Apoptosis-induced inhibition of CD1d-mediated antigen presentation: Different roles for caspases and signal transduction pathways

Immunology

Volumn 125, Issue 1, 2008, Pages 80-90

  Khan, Masood A ^a,b,c   Sriram, Venkataraman ^a,b,c   Renukaradhya, Gourapura J ^a,b,c   Du, Wenjun ^d   Gervay Hague, Jacquelyn ^d   Brutkiewicz, Randy R ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen presentation processing; Apoptosis; Signal transduction

Indexed keywords

CASPASE; CASPASE INHIBITOR; CD1D ANTIGEN; CERAMIDE; DNA TOPOISOMERASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C DELTA;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; APOPTOSIS; CAMPTOTHECIN; CASPASES; CELLS, CULTURED; CERAMIDES; COCULTURE TECHNIQUES; FEMALE; GALACTOSYLCERAMIDES; MEPERIDINE; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C-DELTA; SIGNAL TRANSDUCTION;

EID: 49249099290     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02823.x     Document Type: Article

References (64)

1. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991 32: 223 54.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995 267: 1456 62.
3. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001 410: 37 40.
4. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 2005 6: 268 75.
5. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005 11: 725 30.
6. Mansouri A, Ridgway LD, Korapati AL et al. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003 278: 19245 56.
7. Wang WH, Gregori G, Hullinger RL, Andrisani OM. Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-α expression. Mol Cell Biol 2004 24: 10352 65.
8. Hayakawa T, Matsuzawa A, Noguchi T, Takeda K, Ichijo H. The ASK1-MAP kinase pathways in immune and stress responses. Microb Infect 2006 8: 1098 107.
9. Lee ER, Kim JY, Kang YJ et al. Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis. Biochim Biophys Acta 2006 1763: 958 68.
10. Zhao S, Yang YN, Song JG. Ceramide induces caspase-dependent and -independent apoptosis in A-431 cells. J Cell Physiol 2004 199: 47 56.
11. Lin CF, Chen CL, Lin YS. Ceramide in apoptotic signaling and anticancer therapy. Curr Med Chem 2006 13: 1609 16.
12. Galluzzi L, Larochette N, Zamzami N, Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006 25: 4812 30.
13. Stoica BA, Movsesyan VA, Knoblach SM, Faden AI. Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci 2005 29: 355 71.
14. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 2002 20: 55 72.
15. Blazquez C, Galve-Roperh I, Guzman M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J 2000 14: 2315 22.
16. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 2001 13: 2037 46.
17. Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985 260: 14873 8.
18. Kirsch DG, Doseff A, Chau BN et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 1999 274: 21155 61.
19. Lee S, Lee HS, Baek M et al. MAPK signaling is involved in camptothecin-induced cell death. Mol Cell 2002 14: 348 54.
20. Brutkiewicz RR. CD1d ligands: the good, the bad, and the ugly. J Immunol 2006 177: 769 75.
21. Kitamura H, Iwakabe K, Yahata T et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999 189: 1121 8.
22. Brutkiewicz RR, Lin Y, Cho S, Hwang YK, Sriram V, Roberts TJ. CD1d-mediated antigen presentation to natural killer T (NKT) cells. Crit Rev Immunol 2003 23: 403 19.
23. Renukaradhya GJ, Webb TJ, Khan MA, Lin YL, Du W, Gervay-Hague J, Brutkiewicz RR. Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 2005 175: 4301 8.
24. Brutkiewicz RR, Willard CA, Gillett-Heacock KK et al. Protein kinase C δ is a critical regulator of CD1d-mediated antigen presentation. Eur J Immunol 2007 37: 2390 5.
25. Liao YF, Hung YC, Chang WH, Tsay GJ, Hour TC, Hung HC, Liu GY. The PKC δ inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade. Life Sci 2005 77: 707 19.
26. Roberts TJ, Sriram V, Spence PM et al. Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J Immunol 2002 168: 5409 14.
27. + T lymphocytes. Science 1995 268: 863 5.
28. - T cells in mice and humans. J Exp Med 1994 180: 1097 106.
29. Gui M, Li J, Wen LJ, Hardy RR, Hayakawa K. TCR β chain influences but does not solely control autoreactivity of Vα14 Jα281 T cells. J Immunol 2001 167: 6239 46.
30. Du W, Gervay-Hague J. Efficient synthesis of α-galactosyl ceramide analogues using glycosyl iodide donors. Org Lett 2005 7: 2063 5.
31. de Chaves EI, Bussiere M, Vance DE, Campenot RB, Vance JE. Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons. J Biol Chem 1997 272: 3028 35.
32. Shayman JA, Abe A, Hiraoka M. A turn in the road: how studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity. Glycoconj J 2004 20: 25 32.
33. Tomicic MT, Christmann M, Kaina B. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival. Cancer Res 2005 65: 8920 6.
34. Morita M, Motoki K, Akimoto K et al. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J Med Chem 1995 38: 2176 87.
35. Polverino AJ, Patterson SD. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor. J Biol Chem 1997 272: 7013 21.
36. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006 443: 796 802.
37. Pinkoski MJ, Green DR. Apoptosis in the regulation of immune responses. J Rheumatol 2005 74: 19 25.
38. Clark JE, Sarafraz N, Marber MS. Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacol Ther 2007 116: 192 206.
39. Cho SG, Choi EJ. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J Biochem Mol Biol 2002 35: 24 7.
40. Sumbayev VV, Yasinska IM. Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection. Scand J Immunol 2006 63: 391 400.
41. Kanto T, Kalinski P, Hunter OC, Lotze MT, Amoscato AA. Ceramide mediates tumor-induced dendritic cell apoptosis. J Immunol 2001 167: 3773 84.
42. Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med 1996 184: 2411 6.
43. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK (MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38 (SAPK). Cancer Res 2003 63: 1684 95.
44. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006 6: 789 802.
45. Wong SH, Santambrogio L, Strominger JL. Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins. Proc Natl Acad Sci U S A 2004 101: 17783 8.
46. Bonifacino JS, Dell'Angelica EC. Molecular bases for the recognition of tyrosine-based sorting signals. J Cell Biol 1999 145: 923 6.
47. Sugita M, Cao X, Watts GF, Rogers RA, Bonifacino JS, Brenner MB. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 2002 16: 697 706.
48. Cernadas M, Sugita M, van der Wel N et al. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J Immunol 2003 171: 4149 55.
49. Elewaut D, Lawton AP, Nagarajan NA et al. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Vα14i NKT cells. J Exp Med 2003 198: 1133 46.
50. McNiven MA, Thompson HM. Vesicle formation at the plasma membrane and trans-Golgi network: the same but different. Science 2006 313: 1591 4.
51. Rosenwald AG, Pagano RE. Inhibition of glycoprotein traffic through the secretory pathway by ceramide. J Biol Chem 1993 268: 4577 9.
52. Zhou D, Mattner J, Cantu C 3rd. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004 306: 1786 9.
53. + T cell lymphoma by natural killer T (NKT) cells. Proc Natl Acad Sci U S A 2002 99: 8197 202.
54. Paquet C, Sane AT, Beauchemin M, Bertrand R. Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis. Leukemia 2005 19: 784 91.
55. Gomel R, Xiang C, Finniss S, Lee HK, Lu W, Okhrimenko H, Brodie C. The localization of protein kinase Cδ in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Mol Cancer Res 2007 5: 627 39.
56. Majewski M, Bose TO, Sille FC, Pollington AM, Fiebiger E, Boes M. Protein kinase C δ stimulates antigen presentation by class II MHC in murine dendritic cells. Int Immunol 2007 19: 719 32.
57. Bertho N, Blancheteau VM, Setterblad N et al. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-δ isoenzyme. Int Immunol 2002 14: 935 42.
58. Leverkus M, McLellan AD, Heldmann M, Eggert AO, Brocker EB, Koch N, Kampgen E. MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int Immunol 2003 15: 993 1006.
59. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001 15: 897 908.
60. Kang SJ, Cresswell P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J 2002 21: 1650 60.
61. Anderson HA, Bergstralh DT, Kawamura T, Blauvelt A, Roche PA. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J Immunol 1999 163: 5435 43.
62. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 2003 370: 361 71.
63. Seki T, Matsubayashi H, Amano T, Shirai Y, Saito N, Sakai N. Phosphorylation of PKC activation loop plays an important role in receptor-mediated translocation of PKC. Genes Cells 2005 10: 225 39.
64. Albihn A, Mo H, Yang Y, Henriksson M. Camptothecin-induced apoptosis is enhanced by Myc and involves PKCδ signaling. Int J Cancer 2007 121: 1821 9.